These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 7384549

  • 1. Vasoactive intestinal polypeptide (VIP) inhibits prostaglandin-F2 alpha-induced activity of the rabbit myometrium.
    Ottesen B, Wagner G, Fahrenkrug J.
    Prostaglandins; 1980 Mar; 19(3):427-35. PubMed ID: 7384549
    [Abstract] [Full Text] [Related]

  • 2. Effect of vasoactive intestinal polypeptide (VIP) upon myometrial blood flow in non-pregnant rabbit.
    Ottesen B, Fahrenkrug J.
    Acta Physiol Scand; 1981 Jun; 112(2):195-201. PubMed ID: 7315413
    [Abstract] [Full Text] [Related]

  • 3. Vasoactive intestinal polypeptide (VIP) inhibits oxytocin induced activity of the rabbit myometrium.
    Ottesen B, Ulrichsen H, Wagner G, Fahrenkrug J.
    Acta Physiol Scand; 1979 Nov; 107(3):285-87. PubMed ID: 539459
    [No Abstract] [Full Text] [Related]

  • 4. Vasoactive intestinal polypeptide (VIP): effect on rabbit uterine smooth muscle in vivo and in vitro.
    Ottesen B.
    Acta Physiol Scand; 1981 Oct; 113(2):193-9. PubMed ID: 6947684
    [Abstract] [Full Text] [Related]

  • 5. Effects of VIP in the female genital tract.
    Ottesen B, Fahrenkrug J, Wagner G, Ulrichsen H, Einer-Jensen N, Carter AM, Larsen JJ, Stolberg B.
    Endocrinol Jpn; 1980 Dec; 27 Suppl 1():71-8. PubMed ID: 7227322
    [Abstract] [Full Text] [Related]

  • 6. [Effects of vasoactive intestinal polypeptide (VIP) on histamine or prostaglandin F-2alpha-induced bronchoconstriction (author's transl)].
    Hara N, Yosida T, Said SI.
    Nihon Kyobu Shikkan Gakkai Zasshi; 1978 Dec; 16(11):840-5. PubMed ID: 739695
    [No Abstract] [Full Text] [Related]

  • 7. Mechanism of action of vasoactive intestinal polypeptide on myometrial smooth muscle of rabbit and guinea-pig.
    Bolton TB, Lang RJ, Ottesen B.
    J Physiol; 1981 Sep; 318():41-55. PubMed ID: 7320897
    [Abstract] [Full Text] [Related]

  • 8. Increased myometrial blood flow evoked by vasoactive intestinal polypeptide in the non-pregnant goat.
    Carter AM, Einer-Jensen N, Fahrenkrug J, Ottesen B.
    J Physiol; 1981 Jan; 310():471-80. PubMed ID: 7230045
    [Abstract] [Full Text] [Related]

  • 9. Vasoactive intestinal polypeptide is more potent than prostaglandin E2 as a vasodilator and oedema potentiator in rabbit skin.
    Williams TJ.
    Br J Pharmacol; 1982 Nov; 77(3):505-9. PubMed ID: 6958342
    [Abstract] [Full Text] [Related]

  • 10. Interaction of NPY and VIP in regulation of myometrial blood flow and mechanical activity.
    Tenmoku S, Ottesen B, O'Hare MM, Sheikh S, Bardrum B, Hansen B, Walker B, Murphy RF, Schwartz TW.
    Peptides; 1988 Nov; 9(2):269-75. PubMed ID: 3375135
    [Abstract] [Full Text] [Related]

  • 11. Effect of vasoactive intestinal polypeptide (VIP) on the in vitro and in vivo motility of the rabbit reproductive tract.
    Fredericks CM, Ashton SH.
    Fertil Steril; 1982 Jun; 37(6):845-50. PubMed ID: 7084506
    [Abstract] [Full Text] [Related]

  • 12. Distribution and motor effect of VIP in female genital tract.
    Ottesen B, Larsen JJ, Fahrenkrug J, Stjernquist M, Sundler F.
    Am J Physiol; 1981 Jan; 240(1):E32-6. PubMed ID: 7006413
    [Abstract] [Full Text] [Related]

  • 13. Vasoactive intestinal polypeptide and the female genital tract: relationship to reproductive phase and delivery.
    Ottesen B, Ulrichsen H, Fahrenkrug J, Larsen JJ, Wagner G, Schierup L, Søndergaard F.
    Am J Obstet Gynecol; 1982 Jun 15; 143(4):414-20. PubMed ID: 7201240
    [Abstract] [Full Text] [Related]

  • 14. VIP nerve fibres around peripheral blood vessels.
    Uddman R, Alumets J, Edvinsson L, Håkanson R, Sundler F.
    Acta Physiol Scand; 1981 May 15; 112(1):65-70. PubMed ID: 7282406
    [Abstract] [Full Text] [Related]

  • 15. Effect of vasoactive intestinal polypeptide on uterine blood flow in pregnant ewes.
    Clark KE, Austin JE, Stys SJ.
    Am J Obstet Gynecol; 1982 Nov 01; 144(5):497-502. PubMed ID: 7137236
    [Abstract] [Full Text] [Related]

  • 16. Distribution and dilatory effect of vasoactive intestinal polypeptide (VIP) in human cerebral arteries.
    Edvinsson L, Ekman R.
    Peptides; 1984 Nov 01; 5(2):329-31. PubMed ID: 6382196
    [Abstract] [Full Text] [Related]

  • 17. Effects of vasoactive intestinal peptide and pancreatic polypeptide in rabbit intestine.
    Camilleri M, Cooper BT, Adrian TE, Bloom SR, Chadwick VS.
    Gut; 1981 Jan 01; 22(1):14-8. PubMed ID: 6257593
    [Abstract] [Full Text] [Related]

  • 18. Vasoactive intestinal polypeptide as a neurotransmitter in the female genital tract.
    Ottesen B.
    Am J Obstet Gynecol; 1983 Sep 15; 147(2):208-24. PubMed ID: 6137145
    [Abstract] [Full Text] [Related]

  • 19. Role of vasoactive intestinal polypeptide (VIP) in the neurogenic vasodilatation of the portal vein in the rabbit.
    Hellstrand P, Fahrenkrug J, Uddman R, Järhult J.
    Regul Pept; 1985 Nov 28; 12(4):309-16. PubMed ID: 3911302
    [Abstract] [Full Text] [Related]

  • 20. Effects of vasoactive intestinal polypeptide upon ovarian steroids, ovum transport and fertility in the rabbit.
    Fredericks CM, Lundquist LE, Mathur RS, Ashton SH, Landgrebe SC.
    Biol Reprod; 1983 Jun 28; 28(5):1052-60. PubMed ID: 6871308
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.